-
Posted by
Two Blokes Jun 6 -
Filed in
General
-
#TwoBlokesTrading
-
11 views
Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the sector. Asad Haider, Goldman Sachs Global Investment Research lead US pharmaceutical analyst and head of the healthcare business unit, joins Market Domination to discuss key trends in oncology and obesity drug developments ahead of Goldman Sachs's major healthcare conference next week.
